Capsule Filler Resources

  1. How Leading CDMOs Are Driving A Greener Future For Pharma 10/11/2024

    In response to a 2023 Open Letter from leading pharma companies, CDMOs are determining how to adapt their SOPs to improve sustainability and reduce CO2 emissions.

  2. Clinical Trials & Europe: Sponsor And CRO Feedback On Automating Participant Reimbursement 3/16/2022

    Find out why sponsors and CROs in Europe are increasingly turning to technology to automate their patient engagement processes, garnering positive feedback from sites.

  3. The Power Of Patient Preferences: Technology And Payment Automation 2/14/2025

    How can you leverage customizable, simplified payment methods and third-party providers to improve patient convenience in your clinical trial?

  4. Quantifying Sleep In The Real World 5/22/2023

    ActiGraph Chief Scientific Officer Christine Guo speaks to Dr. Jennifer Walsh about her experiences and the surprising insights her team uncovered as they conducted the first RCT to deploy self-reports, actigraphy, and PSG to rigorously examine treatment effect of a medical cannabis product for insomnia.

  5. Aligning New Cancer Therapies With FDA Project FrontRunner 11/22/2024

    Explore questions about the FDA’s Project FrontRunner, including what the project entails, trial design considerations and implications, and the impact on patient safety and site participation.

  6. Biotech And CAR-T Research In China 4/27/2023

    Novotech hosted a webinar highlighting China’s rapidly expanding biotech research. After the event, experts answered questions on biotech and CAR T cell therapy research in China.

  7. How Sponsors Can Make It Easier For Rare Disease Patients And Families To Participate In Trials 8/22/2024

    New research highlights several significant challenges sponsors encounter when conducting clinical trials in rare neurological disorders.

  8. Executive Q&A With SGS' Hudson, NH Bioanalytical Services Facility 12/11/2024

    Explore how SGS's Hudson facility can enhance your drug development process by providing cutting-edge bioanalytical testing solutions and seamless global support.

  9. The Evolution Of The Cell And Gene Therapy Field 9/29/2023

    Lung-I Cheng, Vice President, Cell and Gene Therapy, AmerisourceBergen, discusses emerging trends in the CGT market and details the value of leveraging the expertise of knowledgeable partners and stakeholders.

  10. A Year Of Reflection And Preparation 1/3/2025

    The Trial Master File (TMF) landscape in 2025 will require companies to stay attuned to the evolving ICH E6(R3) guidelines and the full implementation of the CTIS.